ClinicalTrials.gg

Program

EDG-7500

A development code. Also written as “[14C]-EDG-7500”.

Its studies are mostly in Cardiomyopathy, Hypertrophic, led by Edgewise Therapeutics.

Furthest: phase 2, since Mar 18, 20246 company-led studies, 1 open or runningNext primary completion: Dec 2027 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Edgewise Therapeutics61 open or runningphase 2since Mar 18, 2024Aug 13, 2023Dec 2027phase 2 · NCT06347159

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Aug 13, 2023First study: phase 1 study in Healthy SubjectsFirst studyNCT06011317 · 84 enrolled · United States
  2. Mar 18, 2024Phase 2 study in Cardiomyopathy, HypertrophicNCT06347159 · 79 enrolled · United States
  3. Dec 4, 2024Phase 1 study in Healthy VolunteerNCT06738836 · 8 enrolled · United States
  4. Jun 9, 2025Phase 1 study in Renal ImpairmentsNCT07034768 · 37 enrolled · United States
  5. Dec 23, 2025Phase 1 study in Hepatic Impairment (HI)NCT07324616 · 25 enrolled · United States
  6. Mar 3, 2026Phase 1 study in Healthy Adult ParticipantsNCT07456059 · 24 enrolled · United States

Ahead

  1. Dec 2027Primary completion: phase 2 study in Cardiomyopathy, HypertrophicNCT06347159

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 6 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07456059Healthy Adult Participants · United States1CompletedJun 1, 202624
NCT07324616Hepatic Impairment (HI) · United States1CompletedApr 7, 202625
NCT07034768Renal Impairments · United States1CompletedDec 22, 202537
NCT06738836Healthy Volunteer · United States1CompletedJan 17, 20258
NCT06347159Cardiomyopathy, Hypertrophic · United States2Active, not recruitingDec 202779
NCT06011317Healthy Subjects · United States1CompletedMay 23, 202484

How it is read

Names in the registry

  • “EDG-7500”, 6 entries
  • “[14C]-EDG-7500”, 1 entry

Codes read as this program: EDG7500.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.